Last reviewed · How we verify
NCT03106402
Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification
trial testing topical bromfenac sodium hydrate in Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification in 316 participants. Completed in 30 July 2015.
30 June 2015
Quick facts
| Lead sponsor | Kyungpook National University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 316 |
| Start date | 1 October 2013 |
| Primary completion | 30 June 2015 |
| Estimated completion | 30 July 2015 |
Drugs / interventions tested
- topical bromfenac sodium hydrate — full drug profile →
Conditions studied
- Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification — all drugs for Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification →
Sponsor
Kyungpook National University Hospital
Who can join
Eligibility, any sex, with Pseudophakic Cystoid Macular Lesions After Uncomplicated Standard Phacoemulsification. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To assess the incidence, risk factors and clinical courses of cystic macular lesions (CMLs) after uncomplicated phacoemulsification and evaluate the efficacy of topical NSAIDs on the prevention of pseudophakic cystic macular lesions
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03106402
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Kyungpook National University Hospital trials
Trials by the same sponsor.
- NCT07265817 — Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms · NA · not yet recruiting
- NCT06215040 — The Treatment Effect for Asymptomatic Common Bile Duct Stone · recruiting
- NCT05849324 — Intravascular Injection Rate During Lumbar Transforaminal Epidural Block Using Bent or Straight Needles · NA · unknown
- NCT05083026 — Neutralizing Antibody Level After COVID-19 Vaccination · unknown
- NCT05046054 — The Effect of Transcutaneous Electrical Nerve Stimulation on Pain During Propofol Injection · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03106402 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kyungpook National University Hospital
- Last refreshed: 10 April 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03106402.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing